dronedarone has been researched along with Cardiovascular Diseases in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bohn, RL; Bozzi, S; Goehring, EL; Jones, JK; Naccarelli, GV; Pezzullo, J; Sicignano, N; Tamayo, RCSG; Tave, AK | 1 |
| Chen, CY; Chiou, WR; Chuang, JY; Huang, CC; Kuo, JY; Lee, YH; Liao, FC; Lin, PL; Liu, LY; Su, MI; Tsai, CT; Wu, YJ | 1 |
| Badimon, JJ; Halperin, JL; Santos-Gallego, CG; Smith, DA; Zafar, MU | 1 |
| Ariano, C; De Vecchis, R | 1 |
| Leaver, L; Maruthappu, M; Wayne, RP; Young, C | 1 |
| Amlie, J; Carlsen, J; Crijns, H; Gøtzsche, O; Køber, L; Lévy, S; McMurray, JJ; Torp-Pedersen, C | 1 |
| Connolly, SJ; Crijns, HJ; Gaudin, C; Hohnloser, SH; Page, RL; Torp-Pedersen, C; van Eickels, M | 1 |
| Floyd, J | 1 |
| Duray, GZ; Hohnloser, SH; Schmitt, J | 1 |
| Afzal, R; Alings, M; Amerena, J; Atar, D; Avezum, Á; Baret-Cormel, L; Blomström, P; Borggrefe, M; Budaj, A; Camm, AJ; Chen, SA; Ching, CK; Chrolavicius, S; Commerford, P; Connolly, SJ; Dans, A; Davy, JM; Delacrétaz, E; Di Pasquale, G; Diaz, R; Dorian, P; Flaker, G; Golitsyn, S; Gonzalez-Hermosillo, A; Granger, CB; Halperin, JL; Heidbüchel, H; Hohnloser, SH; Joyner, C; Kautzner, J; Kim, JS; Lanas, F; Lewis, BS; Merino, JL; Morillo, C; Murin, J; Narasimhan, C; Paolasso, E; Parkhomenko, A; Peters, NS; Sim, KH; Staiger, C; Stiles, MK; Tanomsup, S; Toivonen, L; Tomcsányi, J; Torp-Pedersen, C; Tse, HF; Vardas, P; Vinereanu, D; Weinling, E; Xavier, D; Yusuf, S; Zhu, J; Zhu, JR | 1 |
| Boiangiu, C; Cohen, M | 1 |
| Åkerborg, Ö; Bégo-Le Bagousse, G; Lindgren, P; Nilsson, J; Rosenquist, M | 1 |
| Salam, AM | 1 |
3 review(s) available for dronedarone and Cardiovascular Diseases
| Article | Year |
|---|---|
Effects of dronedarone on all-cause mortality and on cardiovascular events in patients treated for atrial fibrillation: a meta-analysis of RCTs.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Diseases; Dronedarone; Heart Failure; Humans; Randomized Controlled Trials as Topic; Secondary Prevention; Time Factors | 2019 |
The management of patients with atrial fibrillation and dronedarone's place in therapy.
Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Cardiovascular Diseases; Clinical Trials as Topic; Dronedarone; Heart Rate; Humans; Practice Guidelines as Topic; Risk Factors; Sex Factors | 2011 |
Dronedarone in atrial fibrillation: the aftermath of the PALLAS trial.
Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Diseases; Dronedarone; Drug Monitoring; Early Termination of Clinical Trials; Humans; Randomized Controlled Trials as Topic; Risk Factors | 2012 |
3 trial(s) available for dronedarone and Cardiovascular Diseases
| Article | Year |
|---|---|
Increased mortality after dronedarone therapy for severe heart failure.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cardiovascular Diseases; Cause of Death; Double-Blind Method; Dronedarone; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Treatment Failure; Ventricular Dysfunction, Left | 2008 |
Effect of dronedarone on cardiovascular events in atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cardiovascular Diseases; Creatinine; Double-Blind Method; Dronedarone; Female; Follow-Up Studies; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Risk Factors; Secondary Prevention; Treatment Outcome | 2009 |
Dronedarone in high-risk permanent atrial fibrillation.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiovascular Diseases; Chronic Disease; Digoxin; Double-Blind Method; Dronedarone; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Heart Rate; Hospitalization; Humans; Male; Risk Factors; Stroke | 2011 |
8 other study(ies) available for dronedarone and Cardiovascular Diseases
| Article | Year |
|---|---|
Outcomes Associated with Dronedarone Use in Patients with Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiovascular Diseases; Cohort Studies; Dronedarone; Epidemiologic Studies; Female; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Risk Assessment; Treatment Outcome | 2020 |
Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Diseases; Dronedarone; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Propafenone; Retrospective Studies; Rivaroxaban; Taiwan | 2021 |
Dronedarone exerts anticoagulant and antiplatelet effects independently of its antiarrhythmic actions.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Cardiovascular Diseases; Dronedarone; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests | 2017 |
Reversible acute kidney injury requiring haemodialysis five days after starting dronedarone in a stable 71-year-old man at risk of cardiovascular polypharmacy.
Topics: Acute Kidney Injury; Aged; Amiodarone; Anti-Arrhythmia Agents; Antihypertensive Agents; Cardiovascular Diseases; Dehydration; Diarrhea; Dronedarone; Humans; Hypotension; Male; Pharmacovigilance; Polypharmacy; Renal Dialysis | 2013 |
Dronedarone in atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Diseases; Dronedarone; Hospitalization; Humans; Secondary Prevention | 2009 |
Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiovascular Diseases; Clinical Trials as Topic; Dronedarone; Humans | 2010 |
Dronedarone trial stopped due to excess mortality.
Topics: Amiodarone; Atrial Fibrillation; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Dronedarone; Early Termination of Clinical Trials; Humans | 2011 |
Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation--results for Canada, Italy, Sweden and Switzerland.
Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Cardiovascular Diseases; Cost-Benefit Analysis; Dronedarone; Europe; Health Status; Humans; Models, Economic; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Sex Factors; Survival Analysis | 2013 |